Women’s imaging encompasses many radiology procedures related to women and the diseases that are most prevalent to women such as breast cancer or gynecological issues. Mammogram, breast ultrasound, breast MRI and breast biopsy are the most commonly used procedures.
Two respected radiology organizations have issued a stark warning on the new recommendations, stating that they risk confusing patients and “may contribute to thousands of additional breast cancer deaths each year.”
Keith J. Dreyer, DO, PhD, FACR, American College of Radiology (ACR) Data Science Institute Chief Science Officer, explains how radiology vendors have developed AI app stores to make it easier to access new FDA cleared AI algorithms.
Keith J. Dreyer, DO, PhD, FACR, American College of Radiology (ACR) Data Science Institute Chief Science Officer, explains 5 developments to watch for in radiology artificial intelligence (AI).
A new study highlights the benefits of MRI for determining pregnancy risks related to placental dysfunction, opening doors for earlier care management.
The responses of 1,948 women aged 40 to 49 were detailed recently in Academic Radiology, where researchers offered detailed insight into what factors influence women at average risk of breast cancer to seek or delay screening at certain ages.
The FDA’s Center for Devices and Radiological Health (CDRH) has updated the status of two previously disaccredited mammography operations, rehabilitating the reputation of one while showing the other in limbo.
Since 2006, the FDA has recommended MRI screenings as a way to detect asymptomatic breast implant ruptures—but many patients seem unaware of or are actively ignoring the guidance.